Changjiang Pharmaceutical Group Balance Sheet Health
Financial Health criteria checks 2/6
Changjiang Pharmaceutical Group has a total shareholder equity of CN¥936.2M and total debt of CN¥825.8M, which brings its debt-to-equity ratio to 88.2%. Its total assets and total liabilities are CN¥3.4B and CN¥2.5B respectively. Changjiang Pharmaceutical Group's EBIT is CN¥75.2M making its interest coverage ratio 1. It has cash and short-term investments of CN¥8.6M.
Key information
88.2%
Debt to equity ratio
CN¥825.85m
Debt
Interest coverage ratio | 1x |
Cash | CN¥8.55m |
Equity | CN¥936.20m |
Total liabilities | CN¥2.50b |
Total assets | CN¥3.43b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300391's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥2.0B).
Long Term Liabilities: 300391's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥534.3M).
Debt to Equity History and Analysis
Debt Level: 300391's net debt to equity ratio (87.3%) is considered high.
Reducing Debt: 300391's debt to equity ratio has increased from 20.5% to 88.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 300391 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 300391 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 36.3% each year